This, in turn, enhances the binding of ACTN4 to F-actin and stabilizes F-actin, ultimately resulting in reduced MMP2 expression and decreased migratory ability in colon cancer cells (Figure 7J). This evidence concerns the gene ACTN4 and malignant colon neoplasm.